Mitochondrial Dysfunction in Aging and Metabolic Diseases II

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Aging".

Deadline for manuscript submissions: closed (30 June 2024) | Viewed by 1472

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmacology, Sam and Ann Barshop Institue for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX 78229, USA
Interests: mitochondrial dysfunction; cardiolipin remodeling; aging; metabolic diseases
Special Issues, Collections and Topics in MDPI journals
Department of Pharmacology, Sam and Ann Barshop Institue for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX 78229, USA
Interests: aging; mitochondrial dysfunction; cardiolipin remodeling; mitophagy; mitochondrial transport; innate immune response

Special Issue Information

Dear Colleagues,

Mitochondria are crucial for cellular bioenergetics and play a major role in multiple cellular processes that dictate the fate of a cell. Mitochondrial dysfunction is characterized by a reduced efficiency of oxidative phosphorylation, the generation of free radicals, and reductions in the synthesis of adenosine-5′-triphosphate. Accumulating evidence has suggested that mitochondrial dysfunction plays a critical role in the pathogenesis of aging and age-related metabolic diseases, including type 2 diabetes, obesity, cardiovascular diseases, and neurodegenerative diseases. Mitochondria undergo periodical cycles of fission, fusion, and mitophagy as quality control processes. Defects in such a process cause the accumulation of damaged mitochondria, which in turn decreases oxidative phosphorylation and increases the production of reactive oxygen species. Moreover, mitochondrial DNA (mtDNA) mutations increase in frequency with age, and increased levels of mtDNA mutations also contribute to the onset of aging and age-related diseases. In addition, emerging evidence suggests that mitochondrial phospholipids, such as cardiolipin (CL) and phosphatidylglycerol (PG), play a pivotal role in maintaining mitochondrial integrity and function. Accordingly, mitochondrial membrane phospholipid compositions are directly linked to metabolic rate and life span in a wide variety of animal species. Furthermore, CL is highly prone to oxidative damage by free radicals due to its exclusive location in the mitochondrial membranes where reactive oxygen species are generated. Oxidized CL not only causes mitochondrial dysfunction, but also activates several innate immune pathways, leading to chronic inflammation and cellular senescence in aging and age-related metabolic diseases. Although the underlying molecular pathways in regulating mitochondrial function are complex, it is crucial to understand the nexus of mitochondrial dysfunction in aging and age-related metabolic diseases.

The current Special Issue will accept original studies, reviews, and technical reports in the field of mitochondrial biology and dysfunction, including mitochondrial quality control, oxidative stress, mtDNA integrity, synthesis, and the remodeling of mitochondrial phospholipids in aging and age-related metabolic diseases, written by scientists active in the field.

Dr. Yuguang Shi
Dr. Jun Zhang
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • mitochondrial dysfunction
  • aging
  • metabolic diseases
  • oxidative stress
  • mitophagy
  • mtDNA
  • cellular senescence
  • mitochondrial phospholipids
  • cardiolipin
  • mitochondrial protein and lipid transport
  • mitochondrial dynamics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 2849 KiB  
Article
From Young to Old: Mimicking Neuronal Aging in Directly Converted Neurons from Young Donors
by Nimmy Varghese, Amandine Grimm, M. Zameel Cader and Anne Eckert
Cells 2024, 13(15), 1260; https://doi.org/10.3390/cells13151260 - 26 Jul 2024
Viewed by 1110
Abstract
A substantial challenge in human brain aging is to find a suitable model to mimic neuronal aging in vitro as accurately as possible. Using directly converted neurons (iNs) from human fibroblasts is considered a promising tool in human aging since it retains the [...] Read more.
A substantial challenge in human brain aging is to find a suitable model to mimic neuronal aging in vitro as accurately as possible. Using directly converted neurons (iNs) from human fibroblasts is considered a promising tool in human aging since it retains the aging-associated mitochondrial donor signature. Still, using iNs from aged donors can pose certain restrictions due to their lower reprogramming and conversion efficacy than those from younger individuals. To overcome these limitations, our study aimed to establish an in vitro neuronal aging model mirroring features of in vivo aging by acute exposure on young iNs to either human stress hormone cortisol or the mitochondrial stressor rotenone, considering stress as a trigger of in vivo aging. The impact of rotenone was evident in mitochondrial bioenergetic properties by showing aging-associated deficits in mitochondrial respiration, cellular ATP, and MMP and a rise in glycolysis, mitochondrial superoxide, and mitochondrial ROS; meanwhile, cortisol only partially induced an aging-associated mitochondrial dysfunction. To replicate the in vivo aging-associated mitochondrial dysfunctions, using rotenone, a mitochondrial complex I inhibitor, proved to be superior to the cortisol model. This work is the first to use stress on young iNs to recreate aging-related mitochondrial impairments. Full article
(This article belongs to the Special Issue Mitochondrial Dysfunction in Aging and Metabolic Diseases II)
Show Figures

Graphical abstract

Back to TopTop